Recent Episodes
Watch recent episodes on
PTV News Review
Scroll Left
Scroll Right
F. Hoffmann-La Roche: Alliance Management: An Exclusive Interview




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: F. Hoffmann-La Roche: Alliance Management: An Exclusive Interview
Released on: November 01, 2006. © PharmaVentures Ltd
Visitors: You are watching a 30 seconds preview.
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    Fintan Walton talks to Eric de La Fortelle, Global Head, External Research and Technology, F.
  • Summary
  • Transcript
  • Participants
  • Company
Fintan Walton talks to Eric de La Fortelle, Global Head, External Research and Technology, F. Hoffmann-La Roche, about his role within the Pharma Partnering Group at Roche. Eric outlines the structure of the Pharma Partnering Group and Roche's overall model for alliance management. The discussion covers Roche's long-term alliance with MorphoSys and the integrated approach that has allowed the companies to harness both science and business, and develop and maintain a successful alliance. Eric also highlights the importance of flexibility in management strategy when assessing alliance candidates and gives an overview of what Roche looks for in a potential partner.
Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.
Dr Eric de La Fortelle is Global Head, External Research and Technology, for Roche Pharma Partnering in Basel, Switzerland. He heads a group with a mandate to find and establish contracts, and to manage global alliances with companies offering discovery-stage products and innovative technologies.
F. Hoffmann-La Roche
F. Hoffmann–La Roche Ltd. is a Swiss global health-care company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange.

The company headquarters are located in Basel and the company has many sites around the world - including: Nutley, NJ, Palo Alto, California, Pleasanton, Branchburg, Fishers, Indiana, Florence, South Carolina, Boulder, Colorado and Ponce, Puerto Rico in the US, Welwyn Garden City and Burgess Hill in the UK, Clarecastle in Ireland, Mannheim and Penzberg in Germany, and Shanghai in China.

The company also owns the American biotechnology company Genentech, which is a wholly owned subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals.